ADVANCED COLORECTAL CANCER
Clinical trials for ADVANCED COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for ADVANCED COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat colon cancer: targeted drug shrinks tumors
Disease control CompletedThis study tested a drug called trastuzumab deruxtecan (T-DXd) in 122 people with advanced colorectal cancer that has too much HER2 protein. The goal was to see if the drug could shrink tumors. About 45% of patients had their tumors shrink. This treatment is not a cure, but it ma…
Matched conditions: ADVANCED COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Virtual rehab may offer same benefits as In-Person for advanced cancer patients
Symptom relief CompletedThis study tested whether group-based cancer rehabilitation could work when done virtually instead of in person for people with advanced breast or colorectal cancer. 111 participants were offered either in-person or online sessions to see which was more practical and acceptable. …
Matched conditions: ADVANCED COLORECTAL CANCER
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Scientists seek new clues to tame tough colorectal cancer
Knowledge-focused CompletedThis completed study looked at 29 patients with a hard-to-treat form of advanced colorectal cancer. The goal was to find new ways to group these patients based on the biology of their tumors. This could help doctors choose more effective treatments in the future. The study did no…
Matched conditions: ADVANCED COLORECTAL CANCER
Sponsor: Cancer Trials Ireland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Can genes predict colorectal cancer drug success?
Knowledge-focused CompletedThis study looked at 76 adults with advanced colorectal cancer to find genetic markers that might predict how well a combination of chemotherapy (FOLFOX) and the drug bevacizumab works. The goal was to understand which patients benefit most, not to test a new cure. Participants h…
Matched conditions: ADVANCED COLORECTAL CANCER
Sponsor: Cancer Trials Ireland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC